Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated obesity

Journal of Hepatology

Volumn 33, Issue 5, 2000, Pages 716-724

  Garcia Monzón, Carmelo ^a   Martín Pérez, Elena ^b   Iacono, Oreste Lo ^b   Fernández Bermejo, Miguel ^b   Majano, Pedro L ^b   Apolinario, Arantxa ^b   Larraaga, Eduardo ^b   Moreno Otero, Ricardo ^b  

^a HOSPITAL UNIVERSITARIO SANTA CRISTINA   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Adhesion molecules; Liver fibrosis; Nitric oxide; Nonalcoholic steatohepatitis; Obesity; Risk factors

Indexed keywords

CELL ADHESION MOLECULE; NITRIC OXIDE;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER BIOPSY; LIVER FIBROSIS; LIVER INJURY; MALE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; STEATOSIS;

EID: 0033767987     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80301-3     Document Type: Article

References (51)

1. Obesity: A time bomb to be defused
2. Obesity, health service use, and health care costs among members of a health maintenance organization
3. The effect of age on the association between body-mass index and mortality
4. Nonalcoholic steatohepatitis
5. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance
6. Alcoholic-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury
7. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy analysis of risk factors
8. Nonalcoholic steatohepatitis. A study of 49 patients
9. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
10. Nonalcoholic steatohepatitis: An expanded clinical entity
11. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
12. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity
13. Nonalcoholic steatohepatitis
14. Non-alcoholic steatohepatitis: Another disease of affluence
15. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
16. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic heptitis treated with interferon alfa-2b
17. Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation
18. Chronic hepatitis C in children: A clinical and immunohistochemical comparative study with adult patients
19. Tumor necrosis factor-α production induced in T lymphocytes through the AIM/CD69 activation pathway
20. 3
21. Involvement of the CD4 molecule in a post-activation event on T cell proliferation
22. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies
23. Characterization a CD11c reactive monoclonal antibody (HC1/1) obtained by immunizing with phorbol ester differentiated U937 cell
24. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes
25. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1
26. Vascular adhesion molecule expression in viral chronic hepatitis: Evidence of neoangiogenesis in portal tracts
27. Coherent preventing and management strategies for obesity
28. Waist circumference and abdominal sagittal diameter: Best, simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women
29. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
30. Liver in obesity
31. Science, medicine, and the future: Obesity treatment
32. Over-weight and obesity in the United States: Prevalence and trends, 1960-1994
33. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis
34. Hepatic steatosis: Innocent bystander or guilty party?
35. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice
36. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes
37. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis
38. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes
39. Oxidative damage and tyrosine nitration from peroxynitrite
40. Nitric oxide and liver injury
41. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis associates with histological severity of liver disease
42. Role of oxidative stress generated from mitochondrial electron transport chain and mitochondrial electron status in loss of mitochondrial function and activation of transcription factor nuclear factor-κB: Studies with isolated mitochondria and rat hepatocytes
43. Function and activation of NF-κB in the immune system
44. Hepatitis B virus X protein transactivates the inducible nitric oxide synthase promoter
45. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of the steatohepatitis
46. Augmented production of tumor necrosis factor-alpha in obese mice
47. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
48. Molecular regulation of hepatic fibrogenesis
49. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cell
50. Signal transduction in hepatic stellate cells